1. Home
  2. TLF vs TPST Comparison

TLF vs TPST Comparison

Compare TLF & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tandy Leather Factory Inc.

TLF

Tandy Leather Factory Inc.

N/A

Current Price

$2.64

Market Cap

19.5M

ML Signal

N/A

Logo Tempest Therapeutics Inc.

TPST

Tempest Therapeutics Inc.

N/A

Current Price

$1.01

Market Cap

15.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TLF
TPST
Founded
1980
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
15.6M
IPO Year
2006
2012

Fundamental Metrics

Financial Performance
Metric
TLF
TPST
Price
$2.64
$1.01
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$11.00
AVG Volume (30 Days)
24.6K
245.8K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
32.05%
N/A
EPS Growth
1122.22
N/A
EPS
0.08
N/A
Revenue
$76,324,000.00
$295,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$32.38
N/A
Revenue Growth
2.60
N/A
52 Week Low
$2.20
$0.84
52 Week High
$3.36
$12.22

Technical Indicators

Market Signals
Indicator
TLF
TPST
Relative Strength Index (RSI) 69.55 48.64
Support Level $2.27 $0.84
Resistance Level $2.75 $1.09
Average True Range (ATR) 0.09 0.09
MACD 0.02 0.02
Stochastic Oscillator 66.27 38.94

Price Performance

Historical Comparison
TLF
TPST

About TLF Tandy Leather Factory Inc.

Tandy Leather Factory Inc is a specialty retailers of leather and leathercraft-related items. Its primary line of business is the sale of leather, leather crafts, and related supplies. Its broad line of leather and related products includes leather, leatherworking tools, leather dyes and finishes, and do-it-yourself kits. Its products include Leather, tools, Hardware, Supplies, Kits, Books and Patterns, and Gift cards. The company sells its products primarily through company-owned stores and through orders generated from its global websites, and through direct account representatives in its commercial division. Geographically the company operates within the United States, and Canada. it generates the highest revenue from the United States.

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets. Company's small-molecule product candidate, amezalpat (previously known as TPST-1120), has completed a Phase 2 study in first-line hepatocellular carcinoma and the second small-molecule product candidate is TPST-1495, plans to initiate a Phase 2 study for in familial adenomatous polyposis.

Share on Social Networks: